Spots Global Cancer Trial Database for Effect of the Automatic Surveillance System on Surveillance Rate of Patients With Gastric Premalignant Lesions

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Effect of the Automatic Surveillance System on Surveillance Rate of Patients With Gastric Premalignant Lesions

Official Title: Effect of the Automatic Surveillance System on Surveillance Rate of Patients With Gastric Premalignant Lesions

Study ID: NCT06039917

Conditions

Artificial Intelligence

Surveillance

Interventions

AI based automatic surveillance (AS) system (ENDOANGEL-AS)

Manually remind the patients

Study Description

Brief Summary: In this study, we proposed a prospective study about the effect of the automatic surveillance system on surveillance rate of patients with gastric premalignant lesions. The enrolled patients were divided into group A with intelligent surveillance system, group B with manual reminder, and group C with natural state. The surveillance among the three groups will be compared.

Detailed Description: The adherence of doctors to published surveillance guidelines for patients with gastric premalignant lesions varies greatly, and surveillance of patients is critical but time-consuming. In previous studies we developed an automatic surveillance (AS) system to accurately identify patients with gastric premalignant lesions, assign surveillance intervals for different risks of patients and proactively follow up with patients in time. In this study, we proposed a prospective study about the effect of the automatic surveillance system on surveillance rate of patients with gastric premalignant lesions. The enrolled patients were divided into group A with intelligent surveillance system, group B with manual reminder, and group C with natural state. The surveillance among the three groups will be compared.